Blog

After our law firm was already successful for Syngenta in an UPC preliminary injunction proceedings before the Munich Local Division, the Court of Appeal has now dismissed Sumi Agro's appeal. The following is especially ...

SciRhom, a pioneering biotechnology company based in Martinsried, has successfully raised EUR 63 million in a Series A funding round. This significant investment will drive the development of its innovative iRhom2-targeted antibody therapies, designed to combat autoimmune diseases. The financing round was led by prominent investors, including Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners. Bayern Kapital also contributed, alongside existing backers such as High-Tech Gründerfonds (HTGF) and PhiFund Ventures.  

Founded in 2016, SciRhom ...

Many entrepreneurs and decision-makers feel overwhelmed by trademark law and make unnecessarily expensive mistakes - often out of ignorance. Dr. Rolf Claessen's book changes all that. The author explains trademark law to readers in an understandable way, without legalese, and shows how to recognize risks at an early stage and how to protect and enforce trademarks securely. His knowledge from over 20 years of experience as a patent attorney helps readers to make the right decisions with confidence.

In patent law, the concept of “public prior use” plays a crucial role when assessing whether an invention is novel. An invention is considered new only if it was not accessible to the public before the priority date. Public prior use refers to a situation where the technical teaching was already available to the public prior to the filing date, effectively ...